日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/12/10 | 日証協 | 203,442株 | +149.06% | 174,096株 | +314.61% | 402,319株 | +22.28% | 100,002株 | +155.76% |
2021/12/03 | 日証協 | 81,683株 | -3.23% | 41,990株 | -48.87% | 329,022株 | +1.61% | 39,100株 | -17.16% |
2021/11/26 | 日証協 | 84,413株 | +59.08% | 82,120株 | +150.06% | 323,822株 | +2.66% | 47,200株 | +24.15% |
2021/11/19 | 日証協 | 53,062株 | +16.26% | 32,840株 | +6.55% | 315,422株 | +6.95% | 38,018株 | -33.08% |
2021/11/05 | 日証協 | 55,700株 | +28.58% | 21,100株 | -39.66% | 319,554株 | +6.98% | 35,118株 | -56.8% |
2021/10/29 | 日証協 | 43,320株 | +33.38% | 34,969株 | -2.53% | 298,695株 | -0.08% | 81,299株 | +206.22% |
2021/10/22 | 日証協 | 32,478株 | -20.74% | 35,878株 | +3.75% | 298,923株 | -4.6% | 26,549株 | +7.05% |
2021/10/15 | 日証協 | 40,979株 | +11.36% | 34,580株 | +7.06% | 313,333株 | -1.48% | 24,801株 | +117.55% |
2021/10/08 | 日証協 | 36,799株 | -54.96% | 32,300株 | -94.01% | 318,032株 | -57.35% | 11,400株 | -98.48% |
2021/10/01 | 日証協 | 81,699株 | -41.64% | 538,920株 | +94.61% | 745,632株 | -7.06% | 748,564株 | +93.32% |
2021/09/24 | 日証協 | 139,999株 | +21.34% | 276,920株 | +19.72% | 802,231株 | +13.5% | 387,210株 | +23.91% |
2021/09/17 | 日証協 | 115,379株 | +44.86% | 231,300株 | +252.05% | 706,821株 | +23.03% | 312,500株 | +57% |
2021/09/10 | 日証協 | 79,648株 | +195.56% | 65,700株 | +145.62% | 574,521株 | +55.62% | 199,050株 | +308.73% |
2021/09/03 | 日証協 | 26,948株 | -10.32% | 26,749株 | +85.76% | 369,171株 | +4.22% | 48,700株 | +925.48% |
2021/08/27 | 日証協 | 30,048株 | -19.22% | 14,400株 | -38.91% | 354,220株 | -4.67% | 4,749株 | -77.39% |
2021/08/20 | 日証協 | 37,199株 | -25.9% | 23,571株 | -58.36% | 371,556株 | +2.12% | 21,000株 | -32.87% |
2021/08/13 | 日証協 | 50,199株 | +29.72% | 56,600株 | +72.73% | 363,856株 | +1.14% | 31,281株 | +99.05% |
2021/08/06 | 日証協 | 38,699株 | +11.27% | 32,768株 | +51.28% | 359,755株 | -2.13% | 15,715株 | -6.88% |
2021/07/30 | 日証協 | 34,780株 | -2.52% | 21,660株 | +67.6% | 367,589株 | -2.24% | 16,876株 | -77.97% |
※株式分割は考慮していませんのでご注意ください。
Page Top